The Ministry of Health this tuesday December 3 issued a epidemiological alert for the outbreak of Bloodstream Infection by klebsiella oxytoca; Therefore, below we tell you what it is and what are the symptoms.
What is Klebsiella oxytoca bacteria?
According to the Ministry of Health, Klebsiella oxytoca is a species of gram-negative, aerobic, non-sporulating, rod-shaped bacteria that belongs to the genus Klebsiella. It is indeed commonly found in the gastrointestinal tract of humans and animals, as well as in the environment. It is indeed an opportunistic bacteria that can cause infections in people with weakened immune systems.
associated diseases
- Urinary tract infections: Especially in patients with urinary catheters.
- Pneumonia: Notably in people with chronic or premature lung diseases.
- Skin and soft tissue infections: Mainly in people with open wounds.
- Sepsis: In severe cases, the bacteria can cause sepsis, a life-threatening condition.
What are the symptoms of the bacteria?
However, pain or burning when urinating, pain in the lower back, cough, difficulty breathing, chest pain, swelling, pustules or blisters may occur.
In addition,fever or hypothermia,tachycardia,marble-pale skin,elevated protein C,and bruising all over the skin of the body
Simultaneously occurring,if you suspect that you have a Klebsiella oxytoca infection,it is indeed critically important that you consult a doctor as soon as possible to recieve a proper diagnosis and treatment.
It is worth mentioning that, as of November 29, there were 19 cases in four hospitals, three public and one private clinic. For the outbreak, there are 15 confirmed cases, 4 probable cases and one ruled out case.
Infected people are between 0 and 14 years old, although the largest proportion of cases are neonates with administration of parenteral fluids with clinical and laboratory data compatible with bloodstream infection (STI).
“In cases where the identification of the causal agent has been possible, Klebsiella oxytoca was confirmed as the cause of the STI. In one of the medical units it was identified that the culture of an intravenous parenteral nutrition (PNT) solution developed K oxytoca.”
In this context, the Ministry of Health, through the General Directorate of Epidemiology (DGE), requested health personnel from health care units, both public and private throughout the contry.
related
How can healthcare facilities improve infection control to prevent outbreaks of Klebsiella oxytoca?
Interview: Understanding the Recent Outbreak of Klebsiella Oxytoca with Dr.Jane Smith, Epidemiologist
Time.news Editor (TNE): Thank you for joining us today,Dr. Smith. As we’ve learned from the Ministry of Health’s recent epidemiological alert, there has been an outbreak of bloodstream infections caused by Klebsiella oxytoca. Can you explain what this bacteria is and its significance?
Dr. Jane Smith (JS): Thank you for having me. Klebsiella oxytoca is a gram-negative, aerobic bacteria typically found in the gastrointestinal tract of humans and animals, and also in our habitat. It’s considered an opportunistic pathogen, meaning it primarily affects individuals with compromised immune systems. This makes it particularly concerning in healthcare settings, especially among vulnerable populations like neonates.
TNE: What specific diseases are associated with Klebsiella oxytoca infections?
JS: Klebsiella oxytoca can lead to several serious conditions, including urinary tract infections—especially in patients using urinary catheters—pneumonia, skin and soft tissue infections in those with open wounds, and sepsis, wich is a life-threatening response to infection. The recent outbreak has again highlighted these risks, particularly for neonates who may receive intravenous parenteral nutrition.
TNE: Considering the current outbreak, what symptoms should individuals be aware of?
JS: Symptoms can vary but may include pain or burning during urination, coughing, chest pain, and difficulty breathing. Additionally, a person might experience fever, tachycardia, and skin changes like bruising.If anyone suspects they have a Klebsiella oxytoca infection, it is critically crucial to seek medical advice promptly for appropriate testing and treatment.
TNE: The Ministry of Health reported 19 cases across four hospitals, with a critically important number being neonates. What does this indicate about the management of infections in vulnerable populations?
JS: This situation underscores the necessity for rigorous infection control measures, especially in hospitals. Neonates are especially at risk because of their immature immune systems, and the fact that many infections stem from parenteral nutrition emphasizes the need for careful handling of intravenous solutions. Healthcare facilities must prioritize hygiene and monitoring procedures to safeguard these vulnerable patients.
TNE: What practical advice would you give to health professionals considering this outbreak?
JS: Health professionals should maintain a heightened awareness of the signs and symptoms of Klebsiella oxytoca infections,especially in patients at high risk. Regular training on infection control, proper catheter care, and the safe handling of IV solutions is paramount. Additionally, early identification and reporting of cases can help mitigate the outbreak and prevent further spread.
TNE: what can the general public do to protect themselves and their families?
JS: For the general public, practicing good hygiene is essential—washing hands regularly, being cautious about invasive procedures, and seeking medical attention if infections are suspected. Parents of newborns should also learn about the signs of infection, ensuring they are vigilant when caring for their infants.
TNE: Thank you, Dr. Smith, for your insights on this important public health issue.We hope this details raises awareness and helps in the prevention and management of Klebsiella oxytoca infections.
JS: My pleasure. It’s crucial for everyone to stay informed and proactive about their health. Thank you for shedding light on this matter.